Once pharmaceutical drug products are dispatched for distribution, their efficacy depends on how well they are stored and distributed. The more temperature-sensitive a drug product is, the more challenging it becomes to maintain its integrity through the supply chain. No, we aren’t referring to standard temperative-sensitive pharmaceutical and biological products like vaccines, insulin, or monoclonal antibodies.
We are talking about a specific class of pharmaceutical product that makes their cold chain logistics ubiquitously challenging: Cell therapies.
In this article, we will explore the logistical challenges posed by this immensely sensitive class of drugs, and how they can be maintained.
What are Cell Therapy Products?
Cell therapy products are made from live mammalian cells, mainly human cells that are autologous or allogenic. These products require special cold chain conditions to maintain their viable state throughout storage, distribution, and till distribution.
Unlike standard small molecule temperature-sensitive pharmaceuticals and biologics, cell therapy products are highly labile, remain viable only for a short time, within specific temperature ranges, and require oxygen and other nutrients to stay metabolically active.
Therefore, these products must be delivered during administration or stored in cryogenic storage temperatures to keep the cells alive.
While cold chain logistics are in place for standard temperature-sensitive products, there is a lack of existing cold chain infrastructure in the commercial supply chain to handle the unique requirements of cell and gene therapy products.
Logistical Challenges Posed by Cell Therapy Products
Cell therapy products must be distributed under controlled room temperature or refrigerated conditions. For example, Apligraf® (Organogenesis) is an Allogeneic Cell Therapy product that must be stored at 20–-23°C, whereas ChondroCelect® (TiGenix), an Autologous Cell Therapy product must be stored at 15–-25°C.
Apart from strict temperature requirements, there are various other logistical challenges for cell therapy products. Let’s briefly review each:
Temperature Control
As discussed already, maintaining strict temperature conditions is paramount for cell therapy products. Any deviation can compromise the integrity of the cells, making precise temperature management essential throughout the supply chain.
Complex Supply Chains
The supply chain of these products involves multiple stages, including the collection of cells from patients, transportation to manufacturing sites, and delivery back to clinical sites for administration. Each step requires careful coordination to keep the cells viable and stable.
Real-time Monitoring and Tracking
Given the high value and sensitivity of cell therapy products, real-time monitoring and advanced tracking systems are necessary to ensure end-to-end visibility of shipments, so that any issues can be addressed immediately to prevent product loss.
Regulatory Compliance
Different regions have varying regulatory requirements for the transport of biological materials, including genetically modified organisms and dangerous goods. Compliance with these regulations requires thorough documentation, specialized packaging, and often, additional testing to meet local standards.
Just-in-time Manufacturing and Delivery
Cell therapies require custom manufacturing for individual patients, leaving no room for error. Just-in-time logistics ensure that the right amount of product is delivered precisely when needed, reducing waste and optimizing the supply chain for these perishable products.
Contingency Planning
Robust contingency plans are essential to handle potential disruptions, such as delays caused by natural disasters or logistical errors. For example, backup storage solutions and alternative transportation routes to ensure continuous supply chain integrity.
Best Practices for Maintaining Cell Therapy Cold Chain
We have briefly discussed logistical challenges posed by cell therapy products, and how they can be dealt with. We will now limit most of our discussion to the most critical aspect - mainta...
(All Rights Reserved)